Historical record - last NADAC effective date: 7/17/2024
Product Information
CHLORPROMAZINE 10 MG TABLET is a generic product labeled by Zameer Pharmaceuticals LLC, priced at $0.3827 per EA under NDC 90096013101. Its NADAC has been published 123 times since Apr 13, 2022.
FDA first approved this application on Nov 29, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ChlorproMAZINE Hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Zameer Pharmaceuticals LLCNDC
90096013101
Classification
Generic
Dosage Form
TABLET, SUGAR COATED
Route
ORAL
Effective Date
7/17/2024
Active Ingredients
CHLORPROMAZINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212630FDA Approved
11/29/2021
TE Code
AB
On Market Since
2/5/2022
Pharmacological Classes
Price Statistics
The NADAC for CHLORPROMAZINE 10 MG TABLET has been published 123 times since Apr 13, 2022, and over the history we have for it it has declined 70.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3827 per EA |
|---|---|
| All-time high | $1.2992 (Jun 15, 2022) |
| All-time low | $0.2182 (May 22, 2024) |
| Median price | $0.4588 |
| Average price | $0.6937 |
| Largest weekly change | +128.8% (Sep 7, 2022) |
| Weeks tracked | 123 |
| Tracking since | Apr 13, 2022 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
+19.3%
5Y
N/A
All
-70.5%
Last surveyed Aug 14, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the ChlorproMAZINE Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Zameer Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ChlorproMAZINE Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Phenothiazine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORPROMAZINE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CHLORPROMAZINE 10 MG TABLET, manufactured by Zameer Pharmaceuticals LLC, is $0.3827 per EA (NDC 90096013101), effective Aug 14, 2024.
How has the price of CHLORPROMAZINE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for CHLORPROMAZINE 10 MG TABLET has declined 70.5%. It has been tracked across 123 weekly CMS publications since Apr 13, 2022.
What are the highest and lowest recorded NADAC prices for CHLORPROMAZINE 10 MG TABLET?
Since Apr 13, 2022, the NADAC for CHLORPROMAZINE 10 MG TABLET has ranged from a low of $0.2182 (May 22, 2024) to a high of $1.2992 (Jun 15, 2022), with a median of $0.4588 per EA.
Are there cheaper alternatives to CHLORPROMAZINE 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CHLORPROMAZINE 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CHLORPROMAZINE 10 MG TABLET?
CHLORPROMAZINE 10 MG TABLET (NDC 90096013101) is labeled by Zameer Pharmaceuticals LLC, and CMS classifies it as a generic product.